163 related articles for article (PubMed ID: 24346126)
1. Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
Peintinger F
Curr Opin Obstet Gynecol; 2014 Feb; 26(1):21-6. PubMed ID: 24346126
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling assays in breast cancer: are we ready for prime time?
Gökmen-Polar Y; Badve S
Oncology (Williston Park); 2012 Apr; 26(4):350-7, 361. PubMed ID: 22655528
[TBL] [Abstract][Full Text] [Related]
3. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine: present and future of breast cancer management.
Sabatier R; Gonçalves A; Bertucci F
Crit Rev Oncol Hematol; 2014 Sep; 91(3):223-33. PubMed ID: 24725667
[TBL] [Abstract][Full Text] [Related]
5. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
6. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
7. Genomic subtypes in choosing adjuvant therapy for breast cancer.
Zelnak AB; O'Regan RM
Oncology (Williston Park); 2013 Mar; 27(3):204-10. PubMed ID: 23687790
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in breast cancer.
Morris SR; Carey LA
Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
[TBL] [Abstract][Full Text] [Related]
9. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
10. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
11. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
Brenton JD; Carey LA; Ahmed AA; Caldas C
J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinicopathological markers of prognosis in breast cancer.
Boyle DP; McCourt CM; Matchett KB; Salto-Tellez M
Expert Rev Mol Diagn; 2013 Jun; 13(5):481-98. PubMed ID: 23782255
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer gene expression profiling: clinical trial and practice implications.
Loi S; Desmedt C; Cardoso F; Piccart M; Sotiriou C
Pharmacogenomics; 2005 Jan; 6(1):49-58. PubMed ID: 15723605
[TBL] [Abstract][Full Text] [Related]
16. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
Kaufmann M; Pusztai L;
Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling in breast cancer: towards individualising patient management.
Murphy N; Millar E; Lee CS
Pathology; 2005 Aug; 37(4):271-7. PubMed ID: 16194824
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles as an additional tool to conventional predictive factors to assist in management of early endocrine responsive breast cancer.
Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S13-7. PubMed ID: 20374025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
